参考文献/References:
[1]Gordillo M,Evans T,Gouon-Evans V.Orchestrating liver development[J].Development,2015,142(12):2094-2108.
[2]Siegel RL,Miller KD,Jemal A.Cancer statistics,2018[J].Ca:A Cancer Journal for Clinicians,2018,60(5):277-300.
[3]Islami F,Miller KD,Siegel RL,et al.Disparities in liver cancer occurrence in the United States by race/ethnicity and state[J].CA:A Cancer Journal for Clinicians,2017,67(4):273-289.
[4]Terrault NA,Bzowej NH,Chang KM,et al.AASLD guidelines for treatment of chronic hepatitis B[J].Hepatology,2016,63(1):261-283.
[5]de Martel C,Maucort-Boulch D,Plummer M,et al.World-wide relative contribution of hepatitis B and C viruses in hepatocellular carcinoma[J].Hepatology,2015,62(4):1190-1200.
[6]Charrez B,Qiao L,Hebbard L.Hepatocellular carcinoma and non-alcoholic steatohepatitis: The state of play[J].World J Gastroenterol,2016,22(8):2494-2502.
[7]Julius B,David V,Asham EH,et al.Hepatocellular carcinoma:a review[J].Journal of Hepatocellular Carcinoma,2016(3):41-53.
[8]Ciriello G,Miller ML,Aksoy BA,et al.Emerging landscape of oncogenic signatures across human cancers[J].Nat Genet,2013,45(10):1127-1133.
[9]Jovel J,Lin Z,O'keefe S,et al.A survey of molecular heterogeneity in hepatocellular carcinoma[J].Hepatology Communications,2018,2(8):941-955.
[10]Chakravarthi BV,Goswami MT,Pathi SS,et al.MicroRNA-101 regulated transcriptional modulator SUB1 plays a role in prostate cancer[J].Oncogene,2016,35(49):6330-6340.
[11]Wang HY,Yan LX,Shao Q,et al.Profiling Plasma MicroRNA in Nasopharyngeal Carcinoma with Deep Sequencing[J].Clinical Chemistry,2014,60(5):773-782.
[12]Martinez-Quetglas I,Pinyol R,Dauch D,et al.IGF2 is Upregulated by Epigenetic Mechanisms in Hepatocellular Carcinomas and is an Actionable Oncogene Product in Experimental Models[J].Gastroenterology,2016,151(6):1192-1205.
[13]Tang S,Hu W,Hu J,et al.Hepatitis B virus X protein promotes P3 transcript expression of the insulin-like growth factor 2 gene via inducing hypomethylation of P3 promoter in hepatocellular carcinoma[J].Liver International,2015,35(2):608-619.
[14]Tang S,Chen Y,Feng S,et al.MiR-483-5p promotes IGF-II transcription and is associated with poor prognosis of hepatocellular carcinoma[J].Oncotarget,2017,8(59):99871-99888.
[15]Song F,Chen WX,Lv XB,et al.miR-483-5p determines mitochondrial fission and cisplatin sensitivity in tongue squamous cell carcinoma by targeting FIS1[J].Cancer Letters,2015,362(2):183-191.
[16]Song Q,Xu Y,Yang C,et al.miR-483-5p Promotes Invasion and Metastasis of Lung Adenocarcinoma by Targeting RhoGDI1 and ALCAM[J].Cancer Research,2014,74(11):3031-3042.
[17]Shi L,Liu S,Zhao W,et al.miR-483-5p and miR-486-5p are down-regulated in cumulus cells of metaphase II oocytes from women with polycystic ovary syndrome[J].Reprod Biomed Online,2015,31(4):565-572.
[18]Chen K,He H,Xie Y,et al.miR-125a-3p and miR-483-5p promote adipogenesis via suppressing the RhoA/ROCK1/ERK1/2 pathway in multiple symmetric lipomatosis[J].Sci Rep,2015(5):11909.
[19]Yang ZG,Ma XD,He ZH,et al.miR-483-5p promotes prostate cancer cell proliferation and invasion by targeting RBM5[J].Int Braz J Urol,2017,43(6):1060-1067.
[20]He M,Chen Z,Martin M,et al.miR-483 Targeting of CTGF Suppresses Endothelial-to-Mesenchymal TransitionNovelty and Significance[J].Circulation Research,2017,120(2):354-365.
[21]Chouri E,Servaas NH,Bekker CPJ,et al.Serum microRNA screening and functional studies reveal miR-483-5p as a potential driver of fibrosis in systemic sclerosis[J].Journal of Autoimmunity,2018,89(4):162-170.
相似文献/References:
[1]修朋程,李 腾,李雅林,等.泰山山慈菇对小鼠肝癌的治疗作用及相关免疫机制研究[J].医学信息,2018,31(09):8.[doi:10.3969/j.issn.1006-1959.2018.09.003]
XIU Peng-cheng,LI Teng,LI Ya-lin,et al.Study on the Therapeutic Effect and Mechanism of Taishan Mountain Mushroom on Liver Cancer in Mice[J].Journal of Medical Information,2018,31(08):8.[doi:10.3969/j.issn.1006-1959.2018.09.003]
[2]崔康健,杜成友.肝动脉化疗栓塞联合射频消融治疗肝癌的研究进展[J].医学信息,2018,31(09):16.[doi:10.3969/j.issn.1006-1959.2018.09.005]
CUI Kang-jian,DU Cheng-you.Research Progress of Transcatheter Arterial Chemoembolization Combined with Radiofrequency Ablation for Liver Cancer[J].Journal of Medical Information,2018,31(08):16.[doi:10.3969/j.issn.1006-1959.2018.09.005]
[3]田 明,常伟平.UbcH10在肝癌中的表达及其与预后的关系[J].医学信息,2019,32(12):77.[doi:10.3969/j.issn.1006-1959.2019.12.024]
IAN Ming,CHANG Wei-ping.Expression of UbcH10 in Hepatocellular Carcinoma and Its Relationship with Prognosis[J].Journal of Medical Information,2019,32(08):77.[doi:10.3969/j.issn.1006-1959.2019.12.024]
[4]许 吉.基于知识图谱和专利地图的我国抗肝癌药物研发态势研究[J].医学信息,2018,31(21):19.[doi:10.3969/j.issn.1006-1959.2018.21.007]
XU Ji.Research and Development Situation of Anti-liver Cancer Drugs in China Based on Knowledge Map and Patent Map[J].Journal of Medical Information,2018,31(08):19.[doi:10.3969/j.issn.1006-1959.2018.21.007]
[5]兰福全,李秀云,卢 斌.四种肿瘤标志物对肝癌诊断的临床意义[J].医学信息,2018,31(21):164.[doi:10.3969/j.issn.1006-1959.2018.21.048]
LAN Fu-quan,LI Xiu-yun,LU Bin.The Clinical Significance of Four Tumor Markers in the Diagnosis of Liver Cancer[J].Journal of Medical Information,2018,31(08):164.[doi:10.3969/j.issn.1006-1959.2018.21.048]
[6]李 闯,叶劲松,刘 昕,等.ZBP-89与缺氧信号因子HIF-1α在肝癌细胞中的
相关性研究[J].医学信息,2019,32(15):74.[doi:10.3969/j.issn.1006-1959.2019.15.023]
LI Chuang,YE Jin-song,LIU Xin,et al.Correlation between ZBP-89 and Hypoxia Signaling Factor HIF-1α in Hepatoma Cells[J].Journal of Medical Information,2019,32(08):74.[doi:10.3969/j.issn.1006-1959.2019.15.023]
[7]孙 逊.性化护理对肝癌患者CT引导下射频消融术后
负性情绪及生活质量的影响[J].医学信息,2019,32(17):187.[doi:10.3969/j.issn.1006-1959.2019.17.065]
SUN Xun.Effect of Humanized Nursing on Negative Emotion and Quality of Life after
CT-guided Radiofrequency Ablation in Patients with Liver Cancer[J].Journal of Medical Information,2019,32(08):187.[doi:10.3969/j.issn.1006-1959.2019.17.065]
[8]胡嘉莉,华 琳.miRNA-mRNA双重表达谱在前列腺癌分子调控机制中的作用[J].医学信息,2022,35(16):18.[doi:10.3969/j.issn.1006-1959.2022.16.004]
HU Jia-li,HUA Lin.Role of miRNA-mRNA Dual Expression Profile in Molecular Regulation of Prostate Cancer[J].Journal of Medical Information,2022,35(08):18.[doi:10.3969/j.issn.1006-1959.2022.16.004]
[9]徐 蓓,魏霞丽,常艳琴.肝癌患者术后自我饮食管理体验的质性研究[J].医学信息,2019,32(20):180.[doi:10.3969/j.issn.1006-1959.2019.20.058]
XU Bei,WEI Xia-li,CHANG Yan-qin.Qualitative Study of Postoperative Self-Catering Management Experience in Patients with Liver Cancer[J].Journal of Medical Information,2019,32(08):180.[doi:10.3969/j.issn.1006-1959.2019.20.058]
[10]刘申颖,施彦卿,梅鹏飞,等.超声引导下经皮无水乙醇注射联合射频消融治疗中晚期肝癌的效果[J].医学信息,2019,32(22):87.[doi:10.3969/j.issn.1006-1959.2019.22.026]
LIU Shen-ying,SHI Yan-qing,MEI Peng-fei,et al.Ultrasound-guided Percutaneous Ethanol Injection Combined with Radiofrequency Ablation for Advanced Hepatocellular Carcinoma[J].Journal of Medical Information,2019,32(08):87.[doi:10.3969/j.issn.1006-1959.2019.22.026]